Chronic kidney patients undergoing hemodialysis. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: Administration of cyproheptadine 4mg daily. Intervention 2: Control group: Placebo administration.
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Chronic kidney patients undergoing dialysis between 18 and 80 years of age, at least three months have passed since the start of dialysis. Patients who undergo dialysis twice a week with good efficacy. People's willingness to participate in the project. Absence of accompanying disease (infection, uncompensated heart failure, malignancy, liver cirrhosis, covid-19) that causes the patient's anorexia. Not taking drugs such as tricyclic antidepressants and corticosteroids that increase appetite.
Exclusion criteria
Exclusion criteria: Patient migration or death Dissatisfaction with the continuation of treatment by the patient. If other infectious or chronic diseases occur during the research period. Patients who underwent organ transplant surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appetite. Timepoint: Before and three months after the intervention. Method of measurement: NMA questionnaire.;Anthropometric indicators. Timepoint: Before and three months after the intervention. Method of measurement: Meter.;Laboratory indicators. Timepoint: Before and three months after the intervention. Method of measurement: cycmax. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz sadat Javanmardi
Yasouj University of Medical Sciences
Outcome results
None listed